Shares of Presbia PLC (NASDAQ:LENS) have been given an average broker rating score of 1.00 (Strong Buy) from the one brokers that cover the stock, Zacks Investment Research reports. One equities research analyst has rated the stock with a strong buy rating.
Brokers have set a 1 year consensus price target of $10.00 for the company, according to Zacks. Zacks has also given Presbia an industry rank of 84 out of 255 based on the ratings given to its competitors.
NASDAQ LENS opened at $0.56 on Friday. Presbia has a 12 month low of $0.28 and a 12 month high of $5.50.
Presbia PLC, an ophthalmic device company, develops and markets optical lens implants for treating presbyopia. The company provides the refractive lens for patient surgeries, as well as accessories for procedures. It primarily operates in South Korea, Australia, New Zealand, Italy, the Netherlands, Ireland, Canada, and Germany.
Featured Article: Why is the conference call important?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Presbia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Presbia and related companies with MarketBeat.com's FREE daily email newsletter.